The association between within-visit blood pressure variability and carotid artery atherosclerosis in general population

PLoS One. 2014 May 16;9(5):e97760. doi: 10.1371/journal.pone.0097760. eCollection 2014.

Abstract

Objectives: To determine whether within-visit blood pressure (BP) variability based on three measurements over minutes is associated with increased carotid intima-media thickness (IMT) and plaque in a general population.

Methods: A cross-sectional survey was performed in 2007, and a total of 1222 Beijing community residents aged 50-79 years belonging to part of the Chinese Multi-Provincial Cohort Study (CMCS) were recruited in this study. BP was measured three times at 5-minute intervals during a single visit, and the maximum absolute difference (MAD) between any two readings of three measurements was used to indicate within-visit BP variability. Carotid IMT and plaque scanned by B-mode ultrasound were identified as the surrogate end points in the intermediate stage of atherosclerosis.

Results: After adjustment for established cardiovascular risk factors, the odds ratio (OR) (95% confidence interval (CI)) for increased carotid IMT and internal carotid plaque associated with the highest within-visit diastolic BP (DBP) variability (MAD > mean + standard deviation (SD)) compared with participants in the lowest within-visit DBP variability (MAD ≤ mean -SD) was 4.92 (1.48-16.42) and 6.07 (1.31-28.10), respectively, in the normotensives (P = 0.01; P = 0.02). The OR (95% CI) for internal carotid plaque associated with the highest within-visit systolic BP (SBP) variability (MAD >mean +SD) compared with participants in the lowest within-visit SBP variability (MAD ≤ mean -SD) was 3.54 (1.26-10.00) in the hypertensives on antihypertensive therapy (P = 0.02).

Conclusions: Within-visit DBP variability was associated with increased carotid IMT and internal carotid plaque in the normotensive population, and within-visit SBP variability was associated with internal carotid plaque in hypertensive patients undergoing antihypertensive therapy.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Blood Pressure*
  • Cardiovascular Diseases / prevention & control
  • Carotid Arteries / diagnostic imaging
  • Carotid Arteries / pathology*
  • Carotid Artery Diseases / diagnosis
  • Carotid Artery Diseases / epidemiology
  • Carotid Artery Diseases / pathology*
  • Carotid Artery Diseases / physiopathology*
  • Cohort Studies
  • Female
  • Humans
  • Hypertension / physiopathology
  • Male
  • Middle Aged
  • Prevalence
  • Risk Factors
  • Tunica Intima / pathology
  • Ultrasonography

Grants and funding

This study was supported by the National Program on Key Basic Research Project of China (contract No. 2012CB517806), China National Grants for Science and Technology (contracts No. 2011BAI09B01 and No. 2011BAI11B03), Pfizer Investigator Initiated Research (INSPIIRE) and Beijing Natural Science Foundation (7123208). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.